Cabazitaxel d9 | CAS 1383572-19-7 - Solicitar cotización

Cabazitaxel d9 is chemically (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-11-hydroxy-9-(((2R,3S)-2-hydroxy-3-((((2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)oxy)carbonyl)amino)-3-phenylpropanoyl)oxy)-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. Cabazitaxel d9 is supplied with detailed characterization data compliant with regulatory guideline. Cabazitaxel d9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabazitaxel.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.